GATA2 Full Length Gene Sequencing – Chronic Neutropenia MonoMac Syndrome Mylodysplasia AML Test
Test Details
GATA2 is a transcription factor that plays a critical role in the development and function of hematopoietic cells, including neutrophils, monocytes, and dendritic cells. Mutations in the GATA2 gene have been associated with a range of hematological disorders, including chronic neutropenia, MonoMac syndrome, myelodysplasia, and acute myeloid leukemia (AML).
Full-length gene sequencing of GATA2 can help identify mutations or variants that may be contributing to these disorders. This involves sequencing the entire coding region of the GATA2 gene, as well as its promoter and other regulatory regions, to identify any changes in the DNA sequence that may be causing functional changes in the protein.
In patients with chronic neutropenia, GATA2 mutations may lead to a reduction in the number of circulating neutrophils, which can increase the risk of infections. MonoMac syndrome is characterized by a lack of monocytes and dendritic cells, which can lead to recurrent infections and other immune system abnormalities. Myelodysplasia is a disorder of the bone marrow in which immature blood cells fail to mature properly, leading to anemia, infections, and other complications. AML is a type of blood cancer that can develop from abnormal blood stem cells and can be associated with GATA2 mutations.
Identifying GATA2 mutations through full-length gene sequencing can help clinicians better understand the underlying causes of these disorders and develop targeted treatment strategies.
Test Name
GATA2 Full Length Gene Sequencing Chronic Neutropenia MonoMac Syndrome Mylodysplasia AML Test
Components
- EDTA Vacutainer (2ml)
Price
2800.0 AED
Sample Condition
Bone Marrow/Peripheral Blood
Report Delivery
15 days
Method
Sanger Sequencing
Test Type
Genetics
Doctor
Gynecologist
Test Department
Pre Test Information
Pre Test Information
GATA2 Full Length Gene Sequencing (Chronic Neutropenia, MonoMac Syndrome, Mylodysplasia, AML) can be done with a doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.
Test Name | GATA2 Full length gene sequencing Chronic Neutropenia MonoMac Syndrome Mylodysplasia AML Test |
---|---|
Components | EDTA Vacutainer (2ml) |
Price | 2800.0 AED |
Sample Condition | Bone Marrow\/Peripheral Blood |
Report Delivery | 15 days |
Method | Sanger Sequencing |
Test type | Genetics |
Doctor | Gynecologist |
Test Department: | |
Pre Test Information | GATA2 Full length gene sequencing (Chronic Neutropenia, MonoMac Syndrome, Mylodysplasia, AML) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details |
GATA2 is a transcription factor that plays a critical role in the development and function of hematopoietic cells, including neutrophils, monocytes, and dendritic cells. Mutations in the GATA2 gene have been associated with a range of hematological disorders, including chronic neutropenia, MonoMac syndrome, myelodysplasia, and acute myeloid leukemia (AML). Full-length gene sequencing of GATA2 can help identify mutations or variants that may be contributing to these disorders. This involves sequencing the entire coding region of the GATA2 gene, as well as its promoter and other regulatory regions, to identify any changes in the DNA sequence that may be causing functional changes in the protein. In patients with chronic neutropenia, GATA2 mutations may lead to a reduction in the number of circulating neutrophils, which can increase the risk of infections. MonoMac syndrome is characterized by a lack of monocytes and dendritic cells, which can lead to recurrent infections and other immune system abnormalities. Myelodysplasia is a disorder of the bone marrow in which immature blood cells fail to mature properly, leading to anemia, infections, and other complications. AML is a type of blood cancer that can develop from abnormal blood stem cells and can be associated with GATA2 mutations. Identifying GATA2 mutations through full-length gene sequencing can help clinicians better understand the underlying causes of these disorders and develop targeted treatment strategies. |